Search Result

Results for "

coronary relaxant agonist,

" in MedChemExpress (MCE) Product Catalog:

By Targets:	11β-HSD (1) 5-HT Receptor (546) ADC Cytotoxin (22) ADC Linker (3) Adenosine Receptor (110) Adenylate Cyclase (9) Adhesion G Protein-coupled Receptors (AGPCRs) (3) Adiponectin Receptor (5) Adrenergic Receptor (514) Akt (28) Aldehyde Dehydrogenase (ALDH) (1) Aldose Reductase (2) Amino Acid Derivatives (7) Aminotransferases (Transaminases) (1) AMPK (5) Amylin Receptor (2) Amyloid-β (11) Androgen Receptor (30) Angiotensin Receptor (29) Angiotensin-converting Enzyme (ACE) (4) ANGPTL (1) Antibiotic (42) Antibody-Drug Conjugates (ADCs) (1) AP-1 (2) Apelin Receptor (APJ) (30) Apolipoprotein (2) Apoptosis (226) Arrestin (17) Aryl Hydrocarbon Receptor (44) Atg8/LC3 (1) ATP Citrate Lyase (1) Autophagy (172) Bacterial (82) Bcl-2 Family (10) Beta-lactamase (1) Biochemical Assay Reagents (28) Bombesin Receptor (10) Bradykinin Receptor (14) c-Met/HGFR (1) Calcium Channel (67) Calmodulin (2) CaMK (4) Cannabinoid Receptor (119) Carboxylesterase (CES) (1) Caspase (16) CaSR (22) Cathepsin (2) CCR (3) CD19 (1) CD20 (1) CD28 (2) CD47 (1) CDK (4) CETP (1) CFTR (1) CGRP Receptor (11) Chemerin Receptor (2) Cholecystokinin Receptor (12) Cholinesterase (ChE) (24) ClpP (2) CMV (1) Collagen (4) Complement System (22) COMT (6) Constitutive Androstane Receptor (2) COX (14) CRFR (22) CXCR (28) Cyclin G-associated Kinase (GAK) (2) Cytochrome P450 (49) Dengue Virus (7) Deubiquitinase (1) Dipeptidyl Peptidase (2) DNA/RNA Synthesis (2) Dopamine Receptor (284) Dopamine Transporter (4) Drug Derivative (15) Drug Intermediate (5) Drug Isomer (9) Drug Metabolite (69) Drug-Linker Conjugates for ADC (16) E1/E2/E3 Enzyme (3) EAAT (2) EBI2/GPR183 (3) EGFR (8) Endogenous Metabolite (385) Endothelin Receptor (15) Enterovirus (6) Ephrin Receptor (4) Epigenetic Reader Domain (2) ERK (36) Estrogen Receptor/ERR (110) Eukaryotic Initiation Factor (eIF) (2) FAAH (3) Factor Xa (2) FAP (1) Fatty Acid Synthase (FASN) (1) Ferroptosis (37) FGFR (1) FLAP (1) Flavivirus (7) Fluorescent Dye (5) Formyl Peptide Receptor (FPR) (27) FOXO (1) Free Fatty Acid Receptor (70) Fungal (18) FXR (62) G protein-coupled Bile Acid Receptor 1 (27) G Protein-coupled Receptor Kinase (GRK) (2) G2A (GPR132) (2) GABA Receptor (155) Gap Junction Protein (1) GCGR (76) GDNF Receptor (3) GHSR (34) GLP Receptor (69) Glucocorticoid Receptor (81) Glucokinase (1) GLUT (1) Glutathione Peroxidase (1) Glutathione Reductase (GR) (1) Glycoprotein VI (2) Glycosidase (3) GlyT (6) GnRH Receptor (20) GPR109A (12) GPR119 (23) GPR139 (4) GPR171 (5) GPR35 (19) GPR52 (4) GPR55 (9) GPR6 (1) GPR68 (1) GPR84 (13) GPR88 (9) GSK-3 (2) Guanylate Cyclase (16) HBV (9) HCN Channel (5) HCV (10) HCV Protease (2) HDAC (3) Hedgehog (3) HIF/HIF Prolyl-Hydroxylase (10) Histamine Receptor (100) Histone Demethylase (1) Histone Methyltransferase (12) HIV (22) HMG-CoA Reductase (HMGCR) (3) HSP (2) HSV (21) Hydroxycarboxylic Acid Receptor (HCAR) (9) IFNAR (8) IGF-1R (2) iGluR (116) IKK (2) IKZF Family (2) Imidazoline Receptor (20) Influenza Virus (13) Insecticide (10) Insulin Receptor (11) Integrin (13) Interleukin Related (34) IPK Superfamily (2) Isotope-Labeled Compounds (315) Itk (2) JAK (5) JNK (5) Keap1-Nrf2 (7) Kisspeptin Receptor (5) LDLR (1) Leukotriene Receptor (13) Ligands for Target Protein for PROTAC (2) Liposome (9) Lipoxygenase (2) LPL Receptor (71) LXR (40) mAChR (147) MAP3K (1) MAPKAPK2 (MK2) (1) MARCKS (2) Mas-related G-protein-coupled Receptor (MRGPR) (15) MCHR1 (GPR24) (5) MDM-2/p53 (2) MEK (1) Melanocortin Receptor (53) Melatonin Receptor (34) mGluR (83) MHC (3) MicroRNA (3) Microtubule/Tubulin (3) Mineralocorticoid Receptor (4) Mitochondrial Metabolism (2) Mitophagy (17) MMP (5) Monoamine Oxidase (5) Monoamine Transporter (1) Motilin Receptor (7) mTOR (2) Na+/H+ Exchanger (NHE) (1) Na+/K+ ATPase (1) nAChR (172) NADPH Oxidase (2) Natriuretic Peptide Receptor (NPR) (2) Necroptosis (5) Neurokinin Receptor (31) Neuromedin U Receptor (NMUR) (5) Neuropeptide B/W Receptor (4) Neuropeptide FF Receptor (7) Neuropeptide S Receptor (3) Neuropeptide Y Receptor (60) Neurotensin Receptor (6) NF-κB (47) NO Synthase (21) NOD-like Receptor (NLR) (13) Notch (2) Nuclear Factor of activated T Cells (NFAT) (2) Nuclear Hormone Receptor 4A/NR4A (22) Nucleoside Antimetabolite/Analog (6) Nucleoside Transporters (2) Olfactory Receptor (3) Opioid Receptor (244) Orexin Receptor (OX Receptor) (31) Organoid (2) Orphan Nuclear Receptor (1) Orphan Receptor (20) Orthopoxvirus (1) Oxytocin Receptor (15) P-glycoprotein (2) P-selectin (1) P2X Receptor (12) P2Y Receptor (47) p38 MAPK (20) p62 (1) PACAP Receptor (2) PAK (9) Parasite (38) PARP (1) PCSK9 (2) PD-1/PD-L1 (4) PDHK (1) PDK-1 (1) PERK (3) PGC-1α (5) PGE synthase (2) Phosphatase (7) Phosphodiesterase (PDE) (14) Phospholipase (2) Phytohormone (1) PI3K (10) Piezo Channel (3) PINK1/Parkin (3) PKA (8) PKC (7) PKD (1) PKG (9) Platelet-activating Factor Receptor (PAFR) (5) Potassium Channel (46) PPAR (272) Progesterone Receptor (21) Prostaglandin Receptor (148) PROTACs (2) Protease Activated Receptor (PAR) (43) Proton Pump (6) PTHR (5) Pyroptosis (1) RAR/RXR (81) Ras (8) Reactive Oxygen Species (32) Renin (3) REV-ERB (7) Reverse Transcriptase (3) RGS Protein (1) ROR (62) ROS Kinase (1) RXFP Receptor (17) SARS-CoV (32) Scavenger Receptor Class B type I (SR-BI） (1) Ser/Thr Kinase (1) Serotonin Transporter (25) Serpin (1) Sigma Receptor (51) Sirtuin (2) Smo (13) SOD (7) Sodium Channel (27) Somatostatin Receptor (44) Src (1) STAT (5) Stearoyl-CoA Desaturase (SCD) (1) STING (90) Succinate Dehydrogenase (1) Succinate Receptor 1 (1) Target Protein Ligand-Linker Conjugates (1) Taste Receptor (3) TGF-beta/Smad (16) TGF-β Receptor (5) Thrombin (6) Thrombopoietin Receptor (21) Thyroid Hormone Receptor (45) TNF Receptor (37) Toll-like Receptor (TLR) (208) Trace Amine-associated Receptor (TAAR) (15) Transmembrane Glycoprotein (6) Transthyretin (TTR) (2) TREM receptor (1) Trk Receptor (11) TRP Channel (99) TSH Receptor (4) Tyrosinase (5) UGT (1) Urotensin Receptor (10) Vasopressin Receptor (27) VD/VDR (19) VEGFR (8) Virus Protease (10) VISTA (1) Wnt (15) Xanthine Oxidase (1) YAP (1) Zinc Finger Protein (1) α-synuclein (1) β-catenin (9)
By Research Areas:	Cancer (1099) Cardiovascular Disease (760) Endocrinology (692) Infection (259) Inflammation/Immunology (1230) Metabolic Disease (944) Neurological Disease (2264)
Click Chemistry:	Azide (7) Alkynes (15)
Oligonucleotides:	Antioxidants (1) Nucleotides and their Analogs (1) MicroRNAs (2) Fillers (1) CpG ODNs (37) Emulsifiers (1) Phospholipids (2) Adjuvant (13) Antisense Oligonucleotides (4) Chelating Agents (1) Cholesterol (1)

5767

Inhibitors & Agonists

Screening Libraries

Fluorescent Dye

Biochemical Assay Reagents

705

Peptides

Inhibitory Antibodies

431

Natural
Products

Recombinant Proteins

464

Isotope-Labeled Compounds

Click Chemistry

Oligonucleotides

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-145393

*5-HT2A receptor agonist-1*	5-HT Receptor	Neurological Disease
5-HT2A receptor agonist-1 is a 5-HT2A receptor agonist with the EC₅₀ of 5.54 nM. 5-HT2A receptor agonist-1 can be used for the research of mood disorders .

HY-103148

LY215840	5-HT Receptor	Neurological Disease
LY215840, a 5-HT₇ receptor ligand and a 5-HT₂ receptor antagonist, blocks serotonin-induced relaxation in canine coronary artery .

HY-P3433

Sarafotoxin S6b	Endothelin Receptor	Cardiovascular Disease
Sarafotoxin S6b is a vasoconstrictor peptide, and a non-selective endothelin receptor agonist. Sarafotoxin S6b can induce contraction in isolated human coronary arteries , the K_i values of Coronary artery, Saphenous vein and Coronary artery are 0.27, 0.55 and 19.5 nM, respectively .

HY-165067

14,15-EE-8(Z)-E 14,15-Epoxyeicosa-8(Z)-enoic acid	Drug Derivative	Cardiovascular Disease
14,15-EE-8(Z)-E (14,15-Epoxyeicosa-8(Z)-enoic acid) has potent vasodilator agonist activity in bovine coronary arteries. 14,15-EE-8(Z)-E is a 14,15-EET (HY-113489) analog. EETs represent important mediators of coronary vascular tone .

HY-121130

Dacuronium 17-hydroxypancuronium	Others	Neurological Disease
Dacuronium (17-hydroxypancuronium) is a steroid muscle relaxant .

HY-121340

Emylcamate	Others	Neurological Disease
Emylcamate is a potent muscle relaxant. Emylcamate has the potential for the research of neurological diseases .

HY-111348

Lamifiban Ro 44-9883	Integrin	Cardiovascular Disease
Lamifiban is a nonpeptide glycoprotein IIb/IIIa receptor and platelet aggregation antagonist. Lamifiban in combination with thrombolytic therapy effectively restores coronary arterial patency. Lamifiban is promising for research of acute coronary syndromes .

HY-167659

Isomylamine hydrochloride	Biochemical Assay Reagents	Neurological Disease
Isomylamine hydrochloride is a spasmolytic and smooth muscle relaxant that can be utilized in relevant research or chemical synthesis .

HY-167079A

OPC-18750 hydrochloride	Others	Cardiovascular Disease
OPC-18750 hydrochloride has positive inotropic and coronary vasodilatory effects .

HY-111348A

Lamifiban TFA	Integrin	Cardiovascular Disease
Lamifiban TFA is a nonpeptide glycoprotein IIb/IIIa receptor and platelet aggregation antagonist. Lamifiban TFA in combination with thrombolytic therapy effectively restores coronary arterial patency. Lamifiban TFA is promising for research of acute coronary syndromes .

HY-125463

ANQ9040	nAChR	Neurological Disease
ANQ9040 is a steroidal relaxant. ANQ9040 is a relatively low-affinity and non-depolarizing nicotinic antagonist .

HY-105082

Avitriptan BMS 180048	5-HT Receptor	Cardiovascular Disease Neurological Disease
Avitriptan is a 5-HT_1B/1D receptor agonist, with pK_is of 7.44 ( 5-HT_1B rat), 7.68 ( 5-HT_1B human) and 8.36 ( 5-HT_1D human). Avitriptan constricts the isolated coronary artery. Avitriptan can be used for migraines .

HY-P3563

[Lys4] Sarafotoxin S6c	Endothelin Receptor	Cardiovascular Disease
[Lys4] Sarafotoxin S6c, a sarafotoxin analogue, is a potent and partial agonist of endothelin receptor. [Lys4] Sarafotoxin S6c elicits contraction of pig coronary artery, with an EC₅₀ of 1.5 nM .

HY-127147

Fazadinium bromide AH 8165 bromide	Others	Others
Fazadinium bromide (AH 8165 bromide) is a neuromuscular blocking agent, that can prevent the muscle contraction. Fazadinium bromide can be used as a muscle relaxant during anesthesia .

HY-B1343A

Pridinol	Cholinesterase (ChE)	Neurological Disease
Pridinol is an orally active and potent central anticholinergic agent, and acts as muscle relaxant .

HY-B0262S

Methocarbamol D5	Sodium Channel	Metabolic Disease
Methocarbamol-d₅ is deuterium labeled Methocarbamol. Methocarbamol is an orally active central muscle relaxant and blocks muscular Nav1.4 channel[1].

HY-121966

Riparin Riparin III	Others	Cancer
Riparin is a nonspecific smooth muscle relaxant. Riparin inhibits CaCl2-induced contractions in a reversible and non-competitive manner and can be used in spasmolytic studies .

HY-165544

Decamethonium chloride	Others	Neurological Disease
Decamethonium chloride is a depolarizing neuromuscular blocking agent that can be used to study the mechanism of action of muscle relaxants .

HY-B1343

Pridinol mesylate	Cholinesterase (ChE)	Neurological Disease
Pridinol mesylate is an orally active, blood-brain permeable, muscarinic acetylcholine receptor (mAChR)-directed muscle relaxant. Pridinol mesylate reduces the conduction of impulses to spinal motor neurons and exerts muscle relaxant activity. Pridinol mesylate inhibits skeletal muscle contractures in diseases of both central and peripheral origin and can be used in research in the field of musculoskeletal diseases .

HY-N0301

Thiocolchicoside	GABA Receptor	Neurological Disease Inflammation/Immunology
Thiocolchicoside is a competitive γ-aminobutyric acid type A (GAB_AA) receptor antagonist and glycine receptor agonist in the central nervous system. Thiocolchicoside is a semisynthetic sulfur derivative of colchicoside. Thiocolchicoside is a muscle relaxant and has anti-inflammatory, and analgesic properties .

HY-A0168A

Regadenoson hydrate CVT-3146 hydrate	Adenosine Receptor	Cardiovascular Disease
Regadenoson hydrate (NSC 169186) is a selective A2A adenosine receptor agonist and vasodilator that increases coronary blood flow, can be used in study of myocardial perfusion imaging. Regadenoson hydrate also increases the permeability of the blood-brain barrier (BBB) in rodents, can be used to study increased delivery of agents to the human CNS .

HY-W187973

3-Methylchromone	Others	Cardiovascular Disease
3-Methylchromone is an active compound which can be used in the prevention and research of anginose attacks of coronary origin .

HY-167650

Fletazepam	GABA Receptor	Neurological Disease
Fletazepam is a benzodiazepine derivative with sedative, anxiolytic and muscle relaxant effects. Fletazepam can be utilized in neurological research .

HY-A0168

Regadenoson 1 Publications Verification CVT-3146	Adenosine Receptor	Cardiovascular Disease Cancer
Regadenoson (CVT-3146) is a selective A2A adenosine receptor agonist and vasodilator that increases coronary blood flow, can be used in study of myocardial perfusion imaging. Regadenoson also increases the permeability of the blood-brain barrier (BBB) in rodents, can be used to study increased delivery of agents to the human CNS .

HY-P1112

Sarafotoxin S6a	Endothelin Receptor	Cardiovascular Disease Neurological Disease
Sarafotoxin S6a, a sarafotoxin analogue, is a endothelin receptor agonist and has an ET_A/ET_B selectivity profile similar to that of Endothelin-3 (HY-P0204). Sarafotoxin S6a elicits the pig coronary artery with an EC₅₀ value of 7.5 nM .

HY-P4153

Enlicitide chloride MK-0616 chloride	PCSK9	Cardiovascular Disease
Enlicitide chloride is an orally active inhibitor for PCSK9 that blocks the interaction between LPL receptor and PSCK9, with an IC₅₀ of 2.5 nM. Enlicitide chloride can be used in the study of cardiovascular diseases such as atherosclerosis, hypercholesterolemia, coronary heart disease, metabolic syndrome, acute coronary syndrome or related cardiovascular and cardiometabolic disorders .

HY-P1112A

Sarafotoxin S6a TFA	Endothelin Receptor	Cardiovascular Disease Neurological Disease
Sarafotoxin S6a TFA , a sarafotoxin analogue, is a endothelin receptor agonist and has an ET_A/ET_B selectivity profile similar to that of Endothelin-3 (HY-P0204). Sarafotoxin S6a TFA elicits the pig coronary artery with an EC₅₀ value of 7.5 nM .

HY-B1343R

Pridinol (mesylate) (Standard)	Cholinesterase (ChE)	Neurological Disease
Pridinol (mesylate) (Standard) is the analytical standard of Pridinol (mesylate). This product is intended for research and analytical applications. Pridinol mesylate is an orally active and potent central anticholinergic agent, and acts as muscle relaxant .

HY-122908

Atuliflapon AZD5718	FLAP	Cardiovascular Disease
Atuliflapon (AZD5718) is an orally active inhibitor of FLAP (5?Lipoxygenase activating protein), with an IC₅₀ of 2 nM. Atuliflapon is used in the study for coronary artery disease .

HY-P3875

[Arg-15,20,21,Leu17]-PACAP-Gly-Lys-Arg-NH2 BM-PACAP	PACAP Receptor	Neurological Disease Metabolic Disease
[Arg-15,-20,-21,Leu17]-PACAP-Gly-Lys-Arg-NH2 (BM-PACAP) is a synthetic PACAP 1-27 (HY-P0176) analogue with relaxant effect .

HY-N0301R

Thiocolchicoside (Standard)	GABA Receptor	Neurological Disease Inflammation/Immunology
Thiocolchicoside (Standard) is the analytical standard of Thiocolchicoside. This product is intended for research and analytical applications. Thiocolchicoside is a competitive γ-aminobutyric acid type A (GAB_AA) receptor antagonist and glycine receptor agonist in the central nervous system. Thiocolchicoside is a semisynthetic sulfur derivative of colchicoside. Thiocolchicoside is a muscle relaxant and has anti-inflammatory, and analgesic properties .

HY-A0168R

Regadenoson (Standard)	Adenosine Receptor	Cardiovascular Disease
Regadenoson (Standard) is the analytical standard of Regadenoson. This product is intended for research and analytical applications. Regadenoson (CVT-3146) is a selective A2A adenosine receptor agonist and vasodilator that increases coronary blood flow, can be used in study of myocardial perfusion imaging. Regadenoson also increases the permeability of the blood-brain barrier (BBB) in rodents, can be used to study increased delivery of agents to the human CNS .

HY-165022

(±)14(15)-EpEDE (±)14,15-Epoxyeicosadienoic acid	Endogenous Metabolite	Metabolic Disease
(±)14(15)-EpEDE is a a polyunsaturated fatty acid and can be found in DCU (HY-W013989) -treated porcine coronary endothelial cells .

HY-B0262

Methocarbamol 1 Publications Verification	Sodium Channel	Neurological Disease
Methocarbamol is an orally active central muscle relaxant and blocks muscular Nav1.4 channel. Methocarbamol reversibly affects voltage dependence of inactivation of Nav1.4 channel. Methocarbamol has the potential for muscle spasms and pain syndromes research .

HY-171241

Imolamine	Drug Derivative	Cardiovascular Disease
Imolamine is a potent antiplatelet aggregation agent, is a phenyl aminoxidiazole derivative. Imolamine has the potential for the research of coronary heart disease .

HY-128469

Inaperisone	GABA Receptor	Neurological Disease
Inaperisone is a centrally acting muscle relaxant. Inaperisone can inhibit the micturition reflex by acting indirectly on GABAB receptors in the brainstem .

HY-12424

Zotarolimus 4 Publications Verification ABT-578; A 179578	Drug Derivative	Cardiovascular Disease Inflammation/Immunology Cancer
Zotarolimus (ABT-578) is a derivative of Rapamycin (HY-10219), with anti-proliferative activity. Zotarolimus is an immunosuppressant. Zotarolimus is developed specifically for local delivery from stents for the prevention of coronary artery restenosis .

HY-149554

17-Phenyl trinor Prostaglandin F2α dimethyl amide Bimatoprost dimethyl amide	Others	Neurological Disease
17-Phenyl trinor Prostaglandin F2α dimethyl amide (Bimatoprost dimethyl amide), a 1-OH cyclopentane heptanoic acid, 2-(cycloalkyl or arylalkyl) derivative, is a smooth muscle relaxant. 17-Phenyl trinor Prostaglandin F2α dimethyl amide has the potential for glaucoma research .

HY-113920A

Azumolene 1 Publications Verification EU4093 free base	Calcium Channel	Metabolic Disease
Azumolene (EU4093 free base), a Dantrolene analog, is a muscle relaxant. Azumolene is a ryanodine receptor (RyR) modulator and inhibits the calcium-release through ryanodine receptor. Azumolene can be used for malignant hyperthermia research .

HY-116513

Adrenochrome Adraxone	Drug Metabolite	Cardiovascular Disease Neurological Disease
Adrenochrome (Adraxone) is an oxidation product of Epinephrine. Adrenochrome is a potent coronary constricting agent in the rat heart. Adrenochrome can be used for neurological disorder research .

HY-B0262R

Methocarbamol (Standard)	Sodium Channel	Neurological Disease
Methocarbamol (Standard) is the analytical standard of Methocarbamol. This product is intended for research and analytical applications. Methocarbamol is an orally active central muscle relaxant and blocks muscular Nav1.4 channel. Methocarbamol reversibly affects voltage dependence of inactivation of Nav1.4 channel. Methocarbamol has the potential for muscle spasms and pain syndromes research .

HY-153525

*FXR agonist* 5**	FXR	Metabolic Disease Inflammation/Immunology
FXR agonist 5 (compound 1) is a FXR agonist. FXR agonist 5 can be used for research in diseases or disorders caused by metabolic inflammation .

HY-170973

*KOR agonist* 4**	Opioid Receptor
KOR agonist 4 (compound 39) is an agonist of Kappa Opioid Receptor. KOR agonist 4 is an activator of G-protein signaling. KOR agonist 4 binds with GTPγS with an EC₅₀ of 14 nM and with an E_max of 83 %. KOR agonist 4 demonstrates moderate to high intrinsic clearance in human hepatocytes. KOR agonist 4 exhibits 60- and 810-fold selectivities versus the related mu (MOR) and delta (DOR) opioid receptors. KOR agonist 4 is potential for central nervous system (CNS) disorders research .

HY-126321

*RORγt agonist* 1**	ROR	Cancer
RORγt agonist 1 (compound 14) is a potent, orally bioavailable RORγt agonist with an EC₅₀ of 20.8 nM. RORγt agonist 1 showes high metabolic stability, improved aqueous solubility and excellent mouse PK profile. RORγt agonist 1 is a potential candidate of RORγt agonist for cancer immunotherapy .

HY-163674

*Mincle agonist* 1**	Interleukin Related	Inflammation/Immunology
Mincle agonist 1 (compound 1c) is a Mincle agonist. Mincle agonist 1 can promote IL-1β expression in BMDM cells. Mincle agonist 1 can be used in immune and inflammation related research .

HY-169950

*NMDA agonist* 1**	iGluR	Neurological Disease
NMDA agonist 1 (compound 42d) is a potent NMDA agonist with a K_i value of 96 nM. NMDA agonist 1 acts as a partial agonist of the GluN1/GluN2B complex with an EC₅₀ value of 78 nM .

HY-B0429

Pancuronium dibromide	nAChR	Neurological Disease
Pancuronium dibromide, a bis-quaternary steroid, is a neuromuscular relaxant. Pancuronium dibromide inhibits neuromuscular transmission by competing with acetylcholine for binding sites on nACh receptors. Pancuronium dibromide also inhibits cardiac muscarinic receptors and has a sympathomimetic action .

HY-P1929

Bivalirudin 5+ Cited Publications	Thrombin	Cardiovascular Disease
Bivalirudin, a peptide anticoagulant, is a direct thrombin inhibitor for anticoagulation in the setting of invasive cardiology, particularly percutaneous coronary intervention .

HY-146482

*PPARγ agonist* 6**	PPAR	Cancer
PPARγ agonist 6 (Compound 12) is a potent and selective agonist of PPARγ. PPARγ agonist 6 has the potential for the research of cancer diseases .

HY-146480

*PPARγ agonist* 5**	PPAR	Cancer
PPARγ agonist 5 (Compound 1) is a potent and selective agonist of PPARγ. PPARγ agonist 5 has the potential for the research of cancer diseases .

Cat. No.	Product Name	Category	Target	Chemical Structure

HY-N1179

Tanshinone IIB	Cardiovascular Disease Structural Classification Natural Products Neurological Disease Classification of Application Fields Labiatae Samanea saman (Jacq.) Merr. Source classification Plants Disease Research Fields	Apoptosis
Tanshinone IIB is a major active constituent of the roots of Salvia miltiorrhiza (Danshen) widely used for the research of stroke and coronary heart disease in Asian countries. Tanshinone IIB has a neuroprotective effect via inhibition of apoptosis .

HY-W004284

Heptadecanoic acid 2 Publications Verification	Cardiovascular Disease Structural Classification Microorganisms Classification of Application Fields Ketones, Aldehydes, Acids Source classification Metabolic Disease Endogenous metabolite Disease Research Fields	Apoptosis PI3K Akt
Heptadecanoic acid is an odd-chain saturated fatty acid (OCS-FA) with oral activity. Heptadecanoic acid can inhibit cell proliferation and induce Apoptosis. Heptadecanoic acid has antitumor activity. Heptadecanoic acid is associated with a number of diseases, including coronary heart disease, pre-diabetes and type 2 diabetes, and multiple sclerosis .

HY-W052144

(±) Anabasine 2 Publications Verification	Alkaloids Piperidine Alkaloids Structural Classification Other disease Classification of Application Fields Source classification Disease markers Other Diseases Pyridine Alkaloids Endogenous metabolite Disease Research Fields	Endogenous Metabolite
(±) Anabasine is a biphasic muscle relaxant.

HY-Y0337A

L-Cysteine hydrochloride 5+ Cited Publications	Structural Classification Classification of Application Fields Anti-aging Source classification Metabolic Disease Amino acids Endogenous metabolite Disease Research Fields	Endogenous Metabolite
L-Cysteine hydrochloride is an orally active conditionally essential amino acid, which acts as a precursor for biologically active molecules such as hydrogen sulphide (H2S), glutathione and taurine. L-Cysteine hydrochloride suppresses ghrelin and reduces appetite in rodents. L-Cysteine hydrochloride inhibits Aspergillus flavus growth and AFB synthesis by disrupting cell structure and antioxidant system balance. L-Cysteine hydrochloride enhances relaxant responses of rat aortic rings to NO and reduces responses to endothelium-derived relaxing factor (EDRF) .

HY-W004284R

Heptadecanoic acid (Standard)	Structural Classification Microorganisms Ketones, Aldehydes, Acids Source classification Endogenous metabolite	Apoptosis PI3K Akt
Heptadecanoic acid (Standard) is the analytical standard of Heptadecanoic acid. This product is intended for research and analytical applications. Heptadecanoic acid is an odd-chain saturated fatty acid (OCS-FA) with oral activity. Heptadecanoic acid can inhibit cell proliferation and induce Apoptosis. Heptadecanoic acid has antitumor activity. Heptadecanoic acid is associated with a number of diseases, including coronary heart disease, pre-diabetes and type 2 diabetes, and multiple sclerosis[1].

HY-107276

Yubeinine	Alkaloids Piperidine Alkaloids other families Classification of Application Fields Source classification Plants Disease Research Fields Inflammation/Immunology	Others
Yubeinine is an alkaloid with tracheal relaxant effects .

HY-N2842

α-Amyrin acetate	Other Terpenoids other families Classification of Application Fields Terpenoids Source classification Plants Disease Research Fields Inflammation/Immunology	Others
α-Amyrin acetate, a natural triterpenoid, has anti-inflammatory activity, antispasmodic profile and the relaxant effect .

HY-N8598

Caulophine	Structural Classification Alkaloids Caulophyllum robustum Maxim. Source classification Plants Berberidaceae	Others
Caulophine is a fluoroketone alkaloid isolated from Caulophyllum robustum MAXIM. Caulophine has antioxidant activity and the ability to protect cardiomyocytes from oxidative and ischemic damage, providing potential value for coronary heart disease research .

HY-Y0337AR

L-Cysteine (hydrochloride) (Standard)	Structural Classification Source classification Amino acids Endogenous metabolite	Endogenous Metabolite
L-Cysteine (hydrochloride) (Standard) is the analytical standard of L-Cysteine (hydrochloride). This product is intended for research and analytical applications. L-Cysteine hydrochloride is an orally active conditionally essential amino acid, which acts as a precursor for biologically active molecules such as hydrogen sulphide (H2S), glutathione and taurine. L-Cysteine hydrochloride suppresses ghrelin and reduces appetite in rodents. L-Cysteine hydrochloride inhibits Aspergillus flavus growth and AFB synthesis by disrupting cell structure and antioxidant system balance. L-Cysteine hydrochloride enhances relaxant responses of rat aortic rings to NO and reduces responses to endothelium-derived relaxing factor (EDRF) [4].

HY-106888

CS-722 Free base	Structural Classification Natural Products Neurological Disease Classification of Application Fields Source classification Endogenous metabolite Disease Research Fields	Endogenous Metabolite
CS-722 Free base is a synthesized centrally acting muscle relaxant, and has a muscle relaxant activity and depressant effectson the spinal reflex . CS-722 Free base inhibits spontaneous inhibitory postsynaptic currents and excitatory postsynaptic currents in hippocampal cultures probably by an inhibition of both sodium and calcium currents .

HY-N0852

Benzoylpaeoniflorin	Cardiovascular Disease Other Monoterpenes Classification of Application Fields Paeonia lactiflora Pall. Terpenoids Source classification Plants Paeoniaceae Disease Research Fields	Apoptosis
Benzoylpaeoniflorin, a natural product from Chinese paeony root, has the potential for coronary heart disease by decreasing apoptosis.

HY-I0400

N-Acetylneuraminic acid 3 Publications Verification NANA; Lactaminic acid	Cardiovascular Disease Structural Classification Microorganisms Classification of Application Fields Source classification Endogenous metabolite Disease Research Fields Saccharides Monosaccharides	Tyrosinase Ras Influenza Virus Endogenous Metabolite
N-Acetylneuraminic acid (NANA; Lactaminic acid), a nonphenolic structure, is the predominant form of sialic from Collocalia esculenta. N-Acetylneuraminic acid plays a biological role in myocardial injury, melanoma and viral or bacterial infection. N-Acetylneuraminic acid inhibits melanogenesis by reducing tyrosinase activity and triggers myocardial injury in vitro and in vivo by activation of the Rho/Rho-associated signaling pathway through binding to RhoA and Cdc42. N-Acetylneuraminic acid may prevent high fat diet (HFD)-induced inflammation and oxidative stress, thereby prevents hyperlipidemia-associated inflammation and oxidative stress. N-Acetylneuraminic acid is promising for research in the field of melanoma, coronary artery, obesity-related diseases and hyperlipidemia .

HY-N2005

Cycleanine	Alkaloids Structural Classification Classification of Application Fields Source classification Plants Cissampelos pareira Menispermaceae Inflammation/Immunology Disease Research Fields Alkaloid Dimers	Calcium Channel Apoptosis
Cycleanine is a potent vascular selective Calcium antagonist. Cycleanine has analgesic, muscle relaxant and anti-inflammatory activities. Cycleanine has potential for anti-ovarian cancer acting through the apoptosis pathway .

HY-I0400R

N-Acetylneuraminic acid (Standard)	Structural Classification Microorganisms Source classification Endogenous metabolite Saccharides Monosaccharides	Tyrosinase Ras Influenza Virus Endogenous Metabolite
N-Acetylneuraminic acid (Standard) is the analytical standard of N-Acetylneuraminic acid. This product is intended for research and analytical applications. N-Acetylneuraminic acid (NANA; Lactaminic acid), a nonphenolic structure, is the predominant form of sialic from Collocalia esculenta. N-Acetylneuraminic acid plays a biological role in myocardial injury, melanoma and viral or bacterial infection. N-Acetylneuraminic acid inhibits melanogenesis by reducing tyrosinase activity and triggers myocardial injury in vitro and in vivo by activation of the Rho/Rho-associated signaling pathway through binding to RhoA and Cdc42. N-Acetylneuraminic acid may prevent high fat diet (HFD)-induced inflammation and oxidative stress, thereby prevents hyperlipidemia-associated inflammation and oxidative stress. N-Acetylneuraminic acid is promising for research in the field of melanoma, coronary artery, obesity-related diseases and hyperlipidemia .

HY-B1394

Khellin 1 Publications Verification	Cardiovascular Disease Structural Classification Classification of Application Fields Artemisia cana Pursh Source classification Lignans Phenylpropanoids Umbelliferae Plants Disease Research Fields	EGFR
Khellin is a furochromone that can be isolated from Ammi visnuga L.. Khellin is an EGFR inhibitor with an IC₅₀ of 0.15 µM. Khelline has anti-proliferative activity in vitro. Khellin has antispasmodic and coronary vasodilator effects .

HY-N7648

Atherosperminine Atherospermine	Infection Alkaloids Structural Classification Classification of Application Fields Other Alkaloids Source classification Fissistigma glaucescens Plants Annonaceae Disease Research Fields	Parasite
Atherosperminine (Atherospermine) is a nature occurring alkaloid, has antiplasmodial activities in vitro, with an IC₅₀ of 5.80 μM. Atherosperminine is a good reductant with the ability to chelate metals. Atherosperminine has scavenging activity towards the free radical DPPH, with an IC₅₀ of 29.56 μg/mL. Atherosperminine exerts a non-specific relaxant effect on the trachealis .

HY-N4323

14-Deoxyandrographolide	Structural Classification Andrographis paniculata (Burm. F.) Nees Acanthaceae Terpenoids Source classification Diterpenoids Plants	Calcium Channel Apoptosis Caspase
14-Deoxyandrographolide is a diterpene with calcium channel blocking activity and acts as a uterine smooth muscle relaxant. 14-Deoxyandrographolide stimulates the release of nitric oxide (NO) in endothelial cells. 14-Deoxyandrographolide gradually desensitizes liver cells to TNF-α mediated apoptosis by inducing the release of TNFRSF1A .

HY-B1394R

Khellin (Standard)	Structural Classification Artemisia cana Pursh Source classification Lignans Phenylpropanoids Umbelliferae Plants	EGFR
Khellin (Standard) is the analytical standard of Khellin. This product is intended for research and analytical applications. Khellin is a furochromone that can be isolated from Ammi visnuga L.. Khellin is an EGFR inhibitor with an IC50 of 0.15 μM. Khelline has anti-proliferative activity in vitro. Khellin has antispasmodic and coronary vasodilator effects .

HY-125324

Squalestatin 3	Structural Classification Natural Products Microorganisms Source classification	Endogenous Metabolite
Squalestatin 3 is a secondary metabolite, which can be isolated from Phoma. Squalestatin 3 is an inhibitor for squalene synthase with an IC₅₀ of 6 nM .

HY-N4323R

14-Deoxyandrographolide (Standard)	Structural Classification Andrographis paniculata (Burm. F.) Nees Acanthaceae Terpenoids Source classification Diterpenoids Plants	Calcium Channel Apoptosis Caspase
14-Deoxyandrographolide (Standard) is the analytical standard of 14-Deoxyandrographolide. 14-Deoxyandrographolide is a diterpene with calcium channel blocking activity and acts as a uterine smooth muscle relaxant. 14-Deoxyandrographolide stimulates the release of nitric oxide (NO) in endothelial cells. 14-Deoxyandrographolide gradually desensitizes liver cells to TNF-α mediated apoptosis by inducing the release of TNFRSF1A .

HY-B0642

Isosorbide mononitrate 5 Publications Verification Isosorbide-5-mononitrate	Cardiovascular Disease Structural Classification Natural Products Classification of Application Fields Source classification Endogenous metabolite Disease Research Fields Cancer	Autophagy Endogenous Metabolite Apoptosis
Isosorbide mononitrate (Isosorbide-5-mononitrate) is an orally active nitric acid compound used for angina pectoris by dilating blood vessels and lowering blood pressure. Isosorbide mononitrate increases the viability and proliferation of HUVECs by decreasing Apoptosis and elevated the expressions of vedf, kdrl, pdgfr in zebrafish embryos. Isosorbide mononitrate is promising for research of heart failure and coronary heart disease .

HY-N4192

Toringin	Cardiovascular Disease Monophenols Flavonoids other families Classification of Application Fields Flavones Source classification Phenols Plants Disease Research Fields Docyniopsis tschonoski Cancer	Others
Toringin, a bioflavonoid, is isolated from the bark of Docyniopsis tschonoski. Toringin progressively decreases not only the cis-effect of the expanded CTG repeats but cytotoxicity as well. Exposure to isosakuranetin, Toringin rescues PC12 neuronal cells. Flavonoids are efficacious for ameliorating the RNA gain of function caused by expanded CTG repeats, and have various biological activities and beneficial actions against cancers, coronary heart disease, among other pathologies .

HY-N9410

Lysophosphatidylcholine 18:2 1-Linoleoyl-2-Hydroxy-sn-glycero-3-PC	Infection Structural Classification Natural Products Classification of Application Fields Source classification Disease markers Endocrine diseases Metabolic Disease Endogenous metabolite Disease Research Fields	Endogenous Metabolite
Lysophosphatidylcholine 18:2 (1-Linoleoyl-2-Hydroxy-sn-glycero-3-PC), a lysophospholipid, is a potential biomarker identified from insulin resistance (IR) polycystic ovary syndrome (PCOS). Low plasma Lysophosphatidylcholine 18:2 also has been shown to predict impaired glucose tolerance, insulin resistance, type 2 diabetes, coronary artery disease, and memory impairment .

HY-107802

Breviscapine Breviscapinun	Structural Classification Natural Products Source classification Plants Compositae Erigeron breviscapus (Vant.) Hand.-Mazz.	NF-κB Interleukin Related
Breviscapine is a crude flavonoid extract of Breviscapine, which is more than 85% of the active ingredient, Breviscapine. Breviscapine has a wide range of cardiovascular pharmacological activities, such as increasing blood flow, improving microcirculation, dilating blood vessels, reducing blood viscosity, promoting fibrinolysis, inhibiting platelet aggregation and thrombosis. Breviscapine has been used in the study of cerebral infarction and its sequelae, cerebral thrombosis, coronary heart disease and angina pectoris .

HY-N2913

Ayanin	Psychotria serpens Linn. Structural Classification Natural Products Classification of Application Fields Rubiaceae Plants Inflammation/Immunology Disease Research Fields	Phosphodiesterase (PDE)
Ayanin is a bioflavonoid isolated from Psychotria serpens. Ayanin is a non-selective phosphodiesterase_1-4 inhibitor and can be used for the study of respiratory disease,such as allergic asthma et al .

HY-113342

7-Ketocholesterol 1 Publications Verification	Triterpenes Structural Classification Terpenoids Source classification Endogenous metabolite	Endogenous Metabolite p38 MAPK
7-Ketocholesterol is an oxidation product of cholesterol, widely present in atherosclerotic plaques, and has a stronger atherogenic effect than cholesterol. 7-Ketocholesterol can inhibit the rate-limiting enzymes involved in bile acid and cholesterol synthesis, such as cholesterol 7α-hydroxylase and HMG-CoA reductase. 7-Ketocholesterol exhibits pro-inflammatory effects both in vivo and in vitro and can induce cell apoptosis (apoptosis) .

HY-N2509

Iristectorigenin B Iristectrigenin B	Cardiovascular Disease Natural Products Iridaceae Classification of Application Fields Source classification Phenols Polyphenols Plants Belamcanda chinensis (Linn.) Redouté Disease Research Fields	LXR
Iristectorigenin B (Iristectrigenin B) is a liver X receptor (LXR) modulator. Iristectrigenin B stimulates the transcriptional activity of both LXR-α and LXR-β .

HY-N3216

Nagilactone B	Other Terpenoids Cardiovascular Disease Structural Classification Podocarpus nagi Classification of Application Fields Terpenoids Source classification Podocarpaceae Plants Disease Research Fields	LXR
Nagilactone B is a liver X receptor (LXR) agonist.

HY-N3209

Nelumol A	Structural Classification Ketones, Aldehydes, Acids Source classification Ligularia nelumbifolia (Bur. et Franch.) Hand.-Mazz. Plants Compositae	FXR
Nelumol A is a farnesoid X receptor (FXR) agonist .

HY-N1415

β-Caryophyllene 1 Publications Verification (-)-(E)-Caryophyllene; (−)-β-caryophyllene; (−)-trans-Caryophyllene	Structural Classification Neurological Disease Classification of Application Fields Anti-aging Source classification Plants Endogenous metabolite Infection other families Terpenoids Sesquiterpenes Disease Research Fields Cancer	Cannabinoid Receptor Endogenous Metabolite
β-Caryophyllene is a CB2 receptor agonist.

HY-N7767

Ergocornine	Structural Classification Alkaloids Microorganisms Other Alkaloids Source classification	Dopamine Receptor
Ergocornine, a natural ergot alkaloid, is a dopamine receptor agonist .

HY-113308A

Taurolithocholic acid sodium salt 4 Publications Verification	Structural Classification Animals Classification of Application Fields Source classification Metabolic Disease Disease Research Fields Steroids	Calcium Channel Endogenous Metabolite
Taurolithocholic acid sodium salt, a potent cholestatic agent, is a potent Ca ²⁺ agonist .

HY-W015326

3-Hydroxymandelic Acid	Monophenols Classification of Application Fields Ketones, Aldehydes, Acids Source classification Other Diseases Phenols Endogenous metabolite Disease Research Fields	Endogenous Metabolite
3-Hydroxymandelic Acid, a metabolite of Phenylephrine, Phenylephrine is a α-receptor agonist.

HY-103273

Muristerone A	Structural Classification Ipomoea nil (Linnaeus) Roth Classification of Application Fields Source classification Other Diseases Plants Convolvulaceae Disease Research Fields Steroids	Endogenous Metabolite
Muristerone A is a phytoecdysteroid analog of ecdysone and a potent agonist of ecdysteroid receptor with a K_d of 1 nM .

HY-N3377

Liriodendrin	Structural Classification Natural Products Eucommia ulmoides Oliver Source classification Eucommiaceae Plants	HSP
Liriodendrin is an HSF1 agonist can be isolated from E. ulmoides .

HY-N12093

Cevadine	Structural Classification Alkaloids Other Alkaloids Source classification Veratrum oblongum Loes. Plants Melanthiaceae	Sodium Channel Parasite
Cevadine is a voltage-sensitive sodium channel agonist. Cevadine has insecticidal activity .

HY-50290A

Meluadrine tartrate	Structural Classification Monophenols Classification of Application Fields Source classification Other Diseases Phenols Endogenous metabolite Disease Research Fields	Endogenous Metabolite Adrenergic Receptor
Meluadrine tartrate is a potent agonist of β2 adrenergic receptor .

HY-N10123

Indolokine A5	Alkaloids Classification of Application Fields Source classification Endogenous metabolite Disease Research Fields Indole Alkaloids Cancer	Aryl Hydrocarbon Receptor
Indolokine A5, a catabolite of L-cysteine, is a potent AhR agonist .

HY-115762

4-Hydroxytryptamine creatinine sulfate	Structural Classification Alkaloids Neurological Disease Classification of Application Fields Source classification Endogenous metabolite Disease Research Fields Indole Alkaloids	Endogenous Metabolite
4-Hydroxytryptamine creatinine sulfate, a tryptamine derivative, is a neurotransmitter agonist .

HY-N0175

Cytisinicline 1 Publications Verification Cytisine; Sophorine; Baptitoxine	Alkaloids Structural Classification Classification of Application Fields Leguminosae Source classification Pyridine Alkaloids Metabolic Disease Plants Thermopsis lanceolala R.Br. Disease Research Fields	nAChR
Cytisinicline (Cytisine) is an alkaloid. Cytisinicline (Cytisine) is a partial agonist of α4β2 nAChRs , and partial to full agonist at β4 containing receptors and α7 receptors . Has been used medically to help with smoking cessation .

HY-N3891

Fargesone A	Structural Classification Source classification Magnoliaceae Lignans Yulania biondii (Pamp.) D. L. Fu Phenylpropanoids Plants	FXR
Fargesone A is a potent and selective FXR agonist. Fargesone A shows anti-inflammatory activity .

HY-79593

MRE-269 1 Publications Verification ACT-333679	Structural Classification Classification of Application Fields Ketones, Aldehydes, Acids Source classification Endogenous metabolite Disease Research Fields Endocrinology	Prostaglandin Receptor
MRE-269 is an active metabolite of selexipag, and acts as a selective IP receptor agonist.

HY-N2333

Resiniferatoxin 1 Publications Verification (+)-Resiniferatoxin	Cardiovascular Disease Euphorbia resinifera O. Berg Classification of Application Fields Source classification Euphorbiaceae Plants Disease Research Fields	TRP Channel
Resiniferatoxin ((+)-Resiniferatoxin), is a selective agonist of transient receptor potential vanilloid 1 (TRPV1) receptor agonist. Resiniferatoxin can be isolated from the Euphorbia resinifera plant. Resiniferatoxin eliminates TRPV1+ primary sensory afferents and blunt cardiac sympathetic afferent reflex for a relatively long period .

HY-W014666

Xanthurenic acid 1 Publications Verification	Structural Classification Monophenols Immune System Disorder Microorganisms Ketones, Aldehydes, Acids Disease markers Phenols Endocrine diseases Endogenous metabolite	Endogenous Metabolite mGluR Apoptosis
Xanthurenic acid is a putative endogenous Group II metabotropic glutamate receptor agonist, on sensory transmission in the thalamus.

HY-N6629

3'-Methoxyflavonol	Flavonols Structural Classification Flavonoids Microorganisms Source classification	Neuromedin U Receptor (NMUR)
3'-Methoxyflavonol is a selective agonist of neuromedin U 2 receptor (NMU2R).

HY-104026

L-Kynurenine 10+ Cited Publications	Cardiovascular Disease Structural Classification Human Gut Microbiota Metabolites Neurological Disease Classification of Application Fields Ketones, Aldehydes, Acids Endogenous metabolite Inflammation/Immunology Disease Research Fields	Aryl Hydrocarbon Receptor Endogenous Metabolite
L-Kynurenine is a metabolite of the amino acid L-tryptophan. L-Kynurenine is an aryl hydrocarbon receptor agonist.

HY-N0178

Diosmin 5+ Cited Publications	Cardiovascular Disease Structural Classification Flavonoids Classification of Application Fields Flavones Source classification Rutaceae Plants Citrus Disease Research Fields	Aryl Hydrocarbon Receptor
Diosmin is a flavonoid found in a variety of citrus fruits and also an agonist of the aryl hydrocarbon receptor (AhR).

HY-10002

Calcitriol 50+ Cited Publications 1,25-Dihydroxyvitamin D3	Structural Classification Natural Products Classification of Application Fields Source classification Endogenous metabolite Disease Research Fields Cancer	Drug Metabolite VD/VDR Endogenous Metabolite
Calcitriol is the most active metabolite of vitamin D and also a vitamin D receptor (VDR) agonist.

HY-B0188A

Mianserin hydrochloride Org GB 94	Alkaloids Structural Classification Neurological Disease Classification of Application Fields Leguminosae Other Alkaloids Source classification Crotalaria pallida Ait. Plants Disease Research Fields Endocrinology	Histamine Receptor
Mianserin hydrochloride (Org GB 94) is a H1 receptor inverse agonist and is a psychoactive agent of the tetracyclic antidepressant.

HY-N2548

Turkesterone	Cardiovascular Disease Structural Classification other families Classification of Application Fields Source classification Plants Disease Research Fields Steroids	Others
Turkesterone is a potent ecdysteroid. Turkesterone acts as an ecdysteroid receptor (EcR) agonist in some insect systems .

Cat. No.	Product Name	Chemical Structure

HY-W004284S

Heptadecanoic acid-d3
Heptadecanoic acid-d₃ is the deuterium labeled Heptadecanoic acid. Heptadecanoic acid is an odd chain saturated fatty acid (OCS-FA). Heptadecanoic acid is associated with several diseases, including the incidence of coronary heart disease, prediabetes and type 2 diabetes as well as multiple sclerosis[1].

HY-W004284S1

Heptadecanoic acid-d33
Heptadecanoic acid-d₃₃ is the deuterium labeled Heptadecanoic acid. Heptadecanoic acid is an odd chain saturated fatty acid (OCS-FA). Heptadecanoic acid is associated with several diseases, including the incidence of coronary heart disease, prediabetes and type 2 diabetes as well as multiple sclerosis[1].

HY-B0262S

Methocarbamol D5
Methocarbamol-d₅ is deuterium labeled Methocarbamol. Methocarbamol is an orally active central muscle relaxant and blocks muscular Nav1.4 channel[1].

HY-160266

*THR-β agonist* 7**
THR-β agonist-1 (Example 2) is a THR-β agonist, with EC₅₀ values of 52 nM and 1017 nM for THR-β and THR-α, respectively .

HY-B0252S3

Hydrochlorothiazide-15N2,13C,d2

Hydrochlorothiazide- ¹⁵N₂, ¹³C,d₂ is ¹⁵N and deuterated labeled Hydrochlorothiazide (HY-B0252). Hydrochlorothiazide (HCTZ), an orally active diuretic agent of the thiazide class, inhibits transforming TGF-β/Smad signaling pathway. Hydrochlorothiazide has direct vascular relaxant effects via opening of the calcium-activated potassium (KCA) channel. Hydrochlorothiazide improves cardiac function, reduces fibrosis and has antihypertensive effect .

HY-169332

*Piezo1 agonist* 1-d2**
Piezo1 agonist 1-d₂ (Compound 12a) is an agonist for Piezo1 with an EC₅₀ of 2.21 μM. Piezo1 agonist 1-d₂ activates the Ca ²⁺-related ERK signaling pathway, and thus promotes the osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs). Piezo1 agonist 1-d₂ ameliorates disuse osteoporosis in the hindlimb-unloading (HU) rat model .

HY-W052144S

(±) Anabasine-d4 dihydrochloride
(±) Anabasine-d₄ (dihydrochloride) is deuterium labeled (±) Anabasine. (±) Anabasine is a biphasic muscle relaxant.

HY-B0740S

Cyclobenzaprine-d3 hydrochloride
Cyclobenzaprine-d₃ (hydrochloride) is the deuterium labeled Cyclobenzaprine hydrochloride. Cyclobenzaprine hydrochloride (MK130 hydrochloride) is a skeletal muscle relaxant and a central nervous system (CNS) depressant.

HY-B1462S1

Chlorzoxazone-13C
Chlorzoxazone- ¹³C is the ¹³C labeled Chlorzoxazone[1]. Chlorzoxazone is a centrally acting muscle relaxant used to treat muscle spasm and the resulting pain or discomfort[2].

HY-B0130S

Perindopril-d4 erbumine
Perindopril-d4 t-butylamine salt is the deuterium labeled Perindopril t-butylamine salt. Perindopril t-butylamine salt is a long-acting ACE inhibitor of which is used to treat high blood pressure, heart failure or stable coronary artery disease .

HY-B1139S

Tolperisone-d10 hydrochloride

Tolperisone-d₁₀ (hydrochloride) is the deuterium labeled Tolperisone hydrochloride. Tolperisone hydrochloride is a centrally acting muscle relaxant, is indicated for use in the treatment of pathologically increased tone of the cross-striated muscle caused by neurological diseases (damage of the pyramidal tract, multiple sclerosis, myelopathy, encephalomyelitis) and of spastic paralysis and other encephalopathies manifested with muscular dystonia.

HY-B0262S1

Methocarbamol-d3
Methocarbamol-d₃ is the deuterium labeled Methocarbamol. Methocarbamol is an orally active central muscle relaxant and blocks muscular Nav1.4 channel. Methocarbamol reversibly affects voltage dependence of inactivation of Nav1.4 channel. Methocarbamol has the potential for muscle spasms and pain syndromes research[1][2][3].

HY-B1283S

Mephenesin-d3
Mephenesin-d₃ is deuterium labeled Mephenesin. Mephenesin is an NMDA receptor antagonist. Mephenesin is also a central muscle relaxant with antianxiety, muscle-paralyzing and anticonvulsant effects. Mephenesin acts directly on the skeletal muscle fibres to produce skeletal muscle relaxation. Mephenesin is promising for research of spasticity or painful muscle spasm .

HY-W707407

Bisoprolol-d7
Bisoprolol-d₇ is deuterium labeled Bisoprolol. Bisoprolol is a potent, selective and orally active β1-adrenergic receptor blocker with little activity on β2-receptor. Bisoprolol has the potential for hypertension, coronary artery disease and stable ventricular dysfunction research .

HY-B1462S

Chlorzoxazone-d3
Chlorzoxazone-d₃ is the deuterium labeled Chlorzoxazone. Chlorzoxazone is a centrally acting muscle relaxant used to treat muscle spasm and the resulting pain or discomfort. It acts on the spinal cord by depressing reflexes.Chlorzoxazone is currently being used as a marker substrate in vitro/vivo studies to quantify cytochrome P450 2E1 (CYP2E1) activity in humans.

HY-B0252S

Hydrochlorothiazid-d2

Hydrochlorothiazid-d₂ is the deuterium labeled Hydrochlorothiazide. Hydrochlorothiazide (HCTZ), an orally active diuretic agent of the thiazide class, inhibits transforming TGF-β/Smad signaling pathway. Hydrochlorothiazide has direct vascular relaxant effects via opening of the calcium-activated potassium (KCA) channel. Hydrochlorothiazide improves cardiac function, reduces fibrosis and has antihypertensive effect[1][2][3].

HY-129029S

Bisoprolol-d5
Bisoprolol-d₅ is the deuterium labeled Bisoprolol. Bisoprolol is a potent, selective and orally active β1-adrenergic receptor blocker. Bisoprolol has little activity on β2-receptor and has the potential for hypertension, coronary artery disease and stable ventricular dysfunction research[1][2].

HY-B0262S2

Methocarbamol-13C,d3
Methocarbamol- ¹³C,d₃ is the ¹³C- and deuterium labeled Methocarbamol. Methocarbamol is an orally active central muscle relaxant and blocks muscular Nav1.4 channel. Methocarbamol reversibly affects voltage dependence of inactivation of Nav1.4 channel. Methocarbamol has the potential for muscle spasms and pain syndromes research[1][2][3].

HY-158186S

Bisoprolol-d6 hemifumarate
Bisoprolol-d₆ fumarate is deuterium labeled Bisoprolol (hemifumarate). Bisoprolol hemifumarate is a potent, selective and orally active β1-adrenergic receptor blocker with little activity on β2-receptor. Bisoprolol hemifumarate has the potential for hypertension, coronary artery disease and stable ventricular dysfunction research .

HY-B1448AS

(Rac)-Benidipine-d7
(Rac)-Benidipine-d₇ is the deuterium labeled Benidipine[1]. Benidipine is a potent and orally active calcium channel antagonist[2]. Benidipine shows anti-apoptosis effects in ischaemic/reperfused myocardial cells[3]. Benidipine increases the activity of endothelial cell-type nitric oxide synthase and improves coronary circulation in hypertensive rats[4].

HY-12542S

Dantrolene-13C3

Dantrolene- ¹³C₃ is the ¹³C₃ labeled Dantrolene. Dantrolene (F368), a muscle relaxant, non-competitively inhibits human erythrocyte glutathione reductase. Ki and IC50 values are 111.6 μM and 52.3 μM, respectively. Dantrolene is a ryanodine receptor antagonist and Ca2+ signaling stabilizer. Dantrolene can be used for the research of muscle spasticity, malignant hyperthermia, Huntington's disease and other neuroleptic malignant syndrome.

HY-B0252S2

Hydrochlorothiazide-13C6

Hydrochlorothiazide- ¹³C₆ is the ¹³C labeled Hydrochlorothiazide[1]. Hydrochlorothiazide (HCTZ), an orally active diuretic agent of the thiazide class, inhibits transforming TGF-β/Smad signaling pathway. Hydrochlorothiazide has direct vascular relaxant effects via opening of the calcium-activated potassium (KCA) channel. Hydrochlorothiazide improves cardiac function, reduces fibrosis and has antihypertensive effect[2][3][4].

HY-B1833S

Afloqualone-d7
Afloqualone-d₇ (HQ-495-d₇) is deuterium labeled Afloqualone. Afloqualone (HQ-495) is an orally active central muscle relaxant and antivertiginous agent that can increase the sensitivity of GABA receptors in neurons of the lateral vestibular nucleus. Afloqualone (HQ-495) can be used in the research of low back pain and neck-arm-shoulder syndrome .

HY-113096S

Prostaglandin D1-d4
Prostaglandin D1-d₄ (PGD1-d₄) is deuterium labeled Prostaglandin D1. Prostaglandin D1 is a prostanoid which causes contractile and relaxant on isolated human pial arteries, it is also an inhibitor of ADP-induced platelet aggregation with an IC₅₀ value of 320 ng/ml. Prostaglandin D1 can be used for metabolic research .

HY-B0252S1

Hydrochlorothiazid-13C,d2

Hydrochlorothiazid- ¹³C,d₂ is the ¹³C- and deuterium labeled Hydrochlorothiazide. Hydrochlorothiazide (HCTZ), an orally active diuretic agent of the thiazide class, inhibits transforming TGF-β/Smad signaling pathway. Hydrochlorothiazide has direct vascular relaxant effects via opening of the calcium-activated potassium (KCA) channel. Hydrochlorothiazide improves cardiac function, reduces fibrosis and has antihypertensive effect[1][2][3].

HY-B1901S

Eperisone-d10 hydrochloride

Eperisone-d₁₀ (hydrochloride) is the deuterium labeled Eperisone hydrochloride. Eperisone Hydrochloride ((±)-Eperisone hydrochloride) is an antispastic agent used for treatment of diseases characterized by muscle stiffness and pain. It works by relaxing both skeletal muscles and vascularsmooth muscles, thus demonstrating avariety of effects such as reduction ofmyotonia, improvement of circulationand suppression of the pain reflex. Eperisone Hydrochloride ((±)-Eperisone hydrochloride) is a centrally acting muscle relaxant inhibiting the pain reflex pathway, having a vasodilator effect[1][2 [3].

HY-131105S

Cimbuterol-d9
Cimbuterol-d₉ is the deuterium labeled Cimbuterol. Cimbuterol is aβ-adrenergic agonist[1].

HY-12721S

Clonidine-d4 hydrochloride
Clonidine-d₄ (hydrochloride) is the deuterium labeled Clonidine. Clonidine hydrochloride is an alpha 2-adrenergic agonist[1].

HY-131104S

Brombuterol-d9
Brombuterol-d₉ is a deuterium labeled Brombuterol. Brombuterol is a β-adrenergic receptor agonist[1].

HY-B0823S

Acetamiprid-d3
Acetamiprid-d₃ is the deuterium labeled Acetamiprid. Acetamiprid is a neonicotinoid insecticide. Acetamiprid is a nAChR agonist[1].

HY-131104AS

Brombuterol-d9 hydrochloride
Brombuterol-d₉ (hydrochloride) is a deuterium labeled Brombuterol hydrochloride. Brombuterol hydrochloride is a β-adrenergic receptor agonist[1].

HY-B0678S

Metaxalone-d3

Metaxalone-d₃ is the deuterium labeled Metaxalone. Metaxalone (AHR438; NSC170959) is an FDA-approved muscle relaxant. Metaxalone acts mainly on the central nervous system and achieves muscle relaxation by inhibiting polysynaptic reflex arcs. In addition, Metaxalone is an inhibitor of MAO-A, which has anti-inflammatory and antioxidant effects. Metaxalone inhibits IL-1β-induced inflammatory phenotype, modulates NF-κB and other related signaling pathways, and decreases MAO-A expression and activity in IL-1β-treated microglia .

HY-B0678S1

Metaxalone-d6

Metaxalone-d₆ is deuterium labeled Metaxalone. Metaxalone (AHR438; NSC170959) is an FDA-approved muscle relaxant. Metaxalone acts mainly on the central nervous system and achieves muscle relaxation by inhibiting polysynaptic reflex arcs. In addition, Metaxalone is an inhibitor of MAO-A, which has anti-inflammatory and antioxidant effects. Metaxalone inhibits IL-1β-induced inflammatory phenotype, modulates NF-κB and other related signaling pathways, and decreases MAO-A expression and activity in IL-1β-treated microglia .

HY-113308AS

Taurolithocholic acid-d4 sodium
Taurolithocholic acid-d₄ (sodium) is the deuterium labeled Taurolithocholic acid (sodium salt). Taurolithocholic acid sodium salt, a potent cholestatic agent, is a potent Ca2+ agonist[1].

HY-Y1176S

Isonipecotic acid-d9
Isonipecotic acid-d₉ is the deuterium labeled Isonipecotic acid[1]. Isonipecotic acid is a GABAA receptor partial agonist[2].

HY-100699S

Clenproperol-d7
Clenproperol-d₇ is the deuterium labeled Clenproperol. Clenproperol is a β2-adrenergic agonist[1].

HY-113308AS2

Taurolithocholic acid-d4-1 sodium
Taurolithocholic acid-d₄-1 (sodium) is the deuterium labeled Taurolithocholic acid. Taurolithocholic acid sodium salt, a potent cholestatic agent, is a potent Ca2+ agonist[1].

HY-113308AS1

Taurolithocholic Acid-d5 sodium salt
Taurolithocholic Acid-d₅ (sodium) is the deuterium labeled Taurolithocholic acid sodium salt. Taurolithocholic acid sodium salt, a potent cholestatic agent, is a potent Ca2+ agonist[1][2].

HY-136435S1

Mapenterol-d6 hydrochloride
Mapenterol-d₆ (hydrochloride) is the deuterium labeled Mapenterol hydrochloride. Mapenterol hydrochloride is a type of β2-adrenoceptor agonist[1][2].

HY-B0197S

Naratriptan-d3
Naratriptan-d₃ is the deuterium labeled Naratriptan[1]. Naratriptan is a selective 5-HT1 receptor subtype agonist[2].

HY-135400S

Glyco-obeticholic acid-d5
Glyco-obeticholic acid-d₅ is the deuterium labeled Glyco-Obeticholic acid. Glyco-obeticholic acid is an active metabolite of Obeticholic acid. Obeticholic acid is a farnesoid X receptor (FXR) agonist[1].

HY-105791S

Sulazepam-d5
Sulazepam-d₅ is a deuterium labeled Sulazepam (HY-105791). Sulazepam is a selective ovarian cancer G protein-coupled receptor (OGR1) agonist[1].

HY-B0010S

Formoterol-d6
Formoterol-d₆ is the deuterium labeled Formoterol. Formoterol ((±)Formoterol) is a potent, selective and long-acting β2-adrenoceptor agonist[1].

HY-17355BS

Dexpramipexole-d3 dihydrochloride
Dexpramipexole-d₃ (dihydrochloride) is the deuterium labeled Dexpramipexole. Dexpramipexole((R)-Pramipexole), also known as R-(+)-Pramipexole, is a neuroprotective agent and weak non-ergoline dopamine agonist[1][2].

HY-104026S

L-Kynurenine-d4
L-Kynurenine-d₄ is the deuterium labeled L-Kynurenine. L-Kynurenine is a metabolite of the amino acid L-tryptophan. L-Kynurenine is an aryl hydrocarbon receptor agonist[1][2].

HY-14773S

(Rac)-Mirabegron-d5
(Rac)-Mirabegron-d₅ is a deuterium labeled (Rac)-Mirabegron. (Rac)-Mirabegron is the racemate of Mirabegron. Mirabegron is a selective β3-adrenoceptor agonist[1].

HY-B0716S2

Urapidil-d4
Urapidil-d₄ is the deuterium labeled Urapidil[1]. Urapidil is an α1 adrenoreceptor antagonist and a 5-HT1A receptor agonist[2].

HY-10002S1

Calcitriol-d3
Calcitriol-d₃ is the deuterium labeled Calcitriol[1]. Calcitriol is the most active metabolite of vitamin D and also a vitamin D receptor (VDR) agonist[2][3][4][5].

HY-107654S

Muscarine-d9 iodide
Muscarine-d₉ (iodide) is the deuterium labeled Muscarine iodide. Muscarine ((+)-Muscarine) iodide is a toxin that can stimulate the parasympathetic nervous system. Muscarine iodide is a prototype muscarinic acetylcholine receptor agonist[1][2].

HY-79593S2

MRE-269-d7
MRE-269-d₇ is deuterium labeled MRE-269 (HY-79593). MRE-269 is an active metabolite of selexipag, and acts as a selective IP receptor agonist[1][2].

Inquiry Online

Your information is safe with us. * Required Fields.

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks